Androgen Receptor Inhibitors are a class of medications that block the action of androgens, which are male hormones like testosterone. These inhibitors are primarily used in the treatment of certain types of prostate cancer, where androgens can promote cancer cell growth. By preventing androgens from binding to their receptors, these drugs help slow down or stop the progression of the disease. In addition to prostate cancer, Androgen Receptor Inhibitors are being studied for their potential use in other conditions influenced by androgens, such as hormone-sensitive breast cancer. They can be administered in various forms, including pills and injections, depending on the specific treatment plan and patient needs.